Paula Ragan Sells 6,292 Shares of X4 Pharmaceuticals, Inc. (

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Get Rating) CEO Paula Ragan sold 6,292 shares of the firm’s stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $1.95, for a total transaction of $12,269.40. Following the completion of the transaction, the chief executive officer now directly owns 557,245 shares […]

Related Keywords

Stifel Nicolaus , Paula Ragan , York Mellon Corp , Securities Exchange Commission , Nasdaq , Virtu Financial , Pharmaceuticals Company Profile , Connor Clark Lunn Investment Management Ltd , Cantor Fitzgerald , Renaissance Technologies , Pharmaceuticals Inc , Pharmaceuticals Daily , Pharmaceuticals Stock Performance , Get Rating , Exchange Commission , New York Mellon Corp , Street Group , Connor Clark , Lunn Investment Management , X4 Pharmaceuticals , Nasdaq Xfor , Wexfor , Medical , Insider Trading , Nsider Trades , Stocks ,